HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GENFLEET-B

32.320

-0.020-0.06%

Volume:2.24M

Turnover:72.86M

Market Cap:12.41B

PE:-5.32

High:34.020

Open:32.360

Low:31.500

Close:32.340

52wk High:52.900

52wk Low:19.600

Shares:384.00M

HK Float Shares:352.00M

Volume Ratio:1.36

T/O Rate:0.64%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-6.070

ROE:--

ROA:-12.49%

PB:5.86

PE(LYR):-5.32

PS:81.69

Loading ...

Overview Company News Filings

Genfleet Therapeutics (Shanghai) Inc - All Entities, Products or Disputed Matters Referenced in Revmed's Correspondence Entirely Unrelated to Co

THOMSON REUTERS

GenFleet says GFH276 IP independent, not tied to RevMed RAS patent disputes

GENFLEET-B Surges Over 7% in Morning Session as Two GFH375/VS-7375 Preclinical Studies Selected for Late-Breaking Research Abstracts

GENFLEET-B Shares Surge Over 4% in Morning Session on Release of Preclinical Data for Pan-RAS Inhibitor GFH276

Stock Track | Genfleet Therapeutics Soars 5.55% Intraday on Strong Revenue Growth, Buyback Plan, and Breakthrough Therapy Designation

GenFleet Therapeutics to Seek Shareholder Nod for Share Mandates, Governance Revamp at 11 May 2026 AGM

Bulletin Express

GenFleet Therapeutics Schedules 11 May 2026 AGM to Approve 2025 Results, Auditor Re-Appointment and Share Buy-Back Mandate

Bulletin Express

GenFleet Therapeutics Sets 11 May 2026 AGM; Targets 10% Share Buy-back and 20% Issuance Mandates

Bulletin Express

Genfleet Therapeutics announces annual general meeting notice

Genfleet Therapeutics publishes 2025 annual report

GENFLEET-B Receives "Buy" Rating and HK$55.63 Target Price in Initiation Coverage by Guojin Securities

Stock Track | Genfleet Therapeutics-B Soars 5.48% Intraday on Breakthrough Therapy Designation for KRAS G12D Inhibitor

GENFLEET-B Shares Surge Over 5% in Morning Session on Second Breakthrough Therapy Designation for GFH375

BRIEF-Genfleet Therapeutics (Shanghai) Says GFH375 Granted Breakthrough Therapy Designation By China's NMPA

GENFLEET-B's GFH375 Granted Second Breakthrough Therapy Designation

GenFleet says China grants breakthrough designation for GFH375 in metastatic pancreatic cancer

Genfleet Therapeutics (Shanghai) Inc - Gfh375 Granted Breakthrough Therapy Designation by China's National Medical Products Administration

THOMSON REUTERS

3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 46.6%

Simply Wall St.

Wellington Management Increases Stake in GENFLEET-B by Approximately 318,247 Shares at Average Price of HK$30.88

GenFleet Therapeutics SEHK 2595 Deepens Losses As Revenue Growth Tests Bullish Narratives

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigermarketb.com/stock/02595/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"02595","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"GENFLEET-B","latestPrice":32.32,"timestamp":1787818111008,"preClose":32.34,"halted":0,"volume":2243400,"delay":0,"changeRate":-0.0006184291898578579,"floatShares":352000000,"shares":384000000,"eps":-6.07,"marketStatus":"Closed","change":-0.02,"latestTime":"08-27 16:08:31","open":32.36,"high":34.02,"low":31.5,"amount":72858610,"amplitude":0.077922,"askPrice":32.4,"askSize":600,"bidPrice":32.32,"bidSize":2400,"shortable":3,"etf":0,"ttmEps":-3.946,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787880600000},"marketStatusCode":5,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":32.34,"openAndCloseTimeList":[[1787794200000,1787803200000],[1787806800000,1787817600000]],"volumeRatio":1.364388,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","floatShares":352000000,"roa":"-12.49%","roe":"--","lyrEps":-6.07,"volumeRatio":1.364388,"shares":384000000,"dividePrice":0,"high":34.02,"amplitude":0.077922,"preClose":32.34,"low":31.5,"week52Low":19.6,"pbRate":"5.86","psRate":"81.69","week52High":52.9,"institutionHeld":0,"latestPrice":32.32,"committee":0.6,"eps":-6.07,"divideRate":0,"volume":2243400,"delay":0,"ttmEps":-3.946,"open":32.36,"prevYearClose":23.78,"prevWeekClose":33.92,"prevMonthClose":27.74,"prevQuarterClose":29.44,"fiveDayClose":32.74,"twentyDayClose":26.78,"sixtyDayClose":30.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02595\",params:#limit:5,,,undefined,":[{"date":"2026-08-21","symbol":"02595","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787275800000,"name":null,"time":"","dateTimestamp":1787241600000,"actualEps":null},{"date":"2026-03-24","symbol":"02595","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774315800000,"name":null,"time":"","dateTimestamp":1774281600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02595\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1785513600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02595\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02595","date":"2026-08-26","current":-8.190573,"percent":0.774336,"low":-19.62221,"twenty":-10.75778,"median":-9.667608,"eighty":-7.286411,"high":-5.69787,"avg":-9.559032,"sd":2.652361,"marketCap":11977656814},"quantilePoints":[{"date":"2025-09-19","current":-19.62221,"twenty":-19.62221,"median":-19.62221,"eighty":-19.62221,"marketCap":14538840523},{"date":"2025-09-26","current":-17.850791,"twenty":-18.989349,"median":-18.569255,"eighty":-18.336187,"marketCap":13192012066},{"date":"2025-10-03","current":-19.06699,"twenty":-19.162092,"median":-18.845312,"eighty":-18.417026,"marketCap":14124431767},{"date":"2025-10-10","current":-11.809112,"twenty":-19.045684,"median":-18.645404,"eighty":-16.087956,"marketCap":11948785798},{"date":"2025-10-17","current":-10.861917,"twenty":-19.006201,"median":-18.336187,"eighty":-11.374297,"marketCap":10981832034},{"date":"2025-10-24","current":-9.567304,"twenty":-18.816504,"median":-12.899451,"eighty":-10.554523,"marketCap":9676444452},{"date":"2025-10-31","current":-9.989391,"twenty":-18.681528,"median":-11.762498,"eighty":-10.081819,"marketCap":10118416331},{"date":"2025-11-07","current":-9.878556,"twenty":-18.646705,"median":-10.725216,"eighty":-9.89625,"marketCap":9999899010},{"date":"2025-11-14","current":-11.674836,"twenty":-18.558233,"median":-10.712517,"eighty":-9.936062,"marketCap":11851732160},{"date":"2025-11-21","current":-10.329745,"twenty":-18.396816,"median":-10.725216,"eighty":-10.005136,"marketCap":10481375629},{"date":"2025-11-28","current":-10.423287,"twenty":-18.142029,"median":-10.678396,"eighty":-10.044836,"marketCap":10614707615},{"date":"2025-12-05","current":-10.100425,"twenty":-16.087956,"median":-10.631034,"eighty":-10.044836,"marketCap":10303599646},{"date":"2025-12-12","current":-10.212238,"twenty":-13.008301,"median":-10.584309,"eighty":-10.020393,"marketCap":10436931633},{"date":"2025-12-19","current":-9.790532,"twenty":-12.136764,"median":-10.450758,"eighty":-9.957409,"marketCap":10029528340},{"date":"2025-12-24","current":-8.945585,"twenty":-11.809112,"median":-10.416014,"eighty":-9.900509,"marketCap":9192499756},{"date":"2026-01-02","current":-8.020182,"twenty":-11.73453,"median":-10.320373,"eighty":-9.861601,"marketCap":8273990514},{"date":"2026-01-09","current":-11.588563,"twenty":-11.683046,"median":-10.309663,"eighty":-9.776189,"marketCap":11985064146},{"date":"2026-01-16","current":-11.693807,"twenty":-11.67863,"median":-10.369243,"eighty":-9.793132,"marketCap":12133210798},{"date":"2026-01-23","current":-10.361602,"twenty":-11.605818,"median":-10.329745,"eighty":-9.783265,"marketCap":10740632270},{"date":"2026-01-30","current":-10.919089,"twenty":-11.483053,"median":-10.385171,"eighty":-9.793132,"marketCap":11370255541},{"date":"2026-02-06","current":-11.146899,"twenty":-11.598147,"median":-10.450758,"eighty":-9.8258,"marketCap":11636919514},{"date":"2026-02-13","current":-10.659945,"twenty":-11.483053,"median":-10.58187,"eighty":-9.869606,"marketCap":11192479558},{"date":"2026-02-20","current":-10.145441,"twenty":-11.446311,"median":-10.573435,"eighty":-9.881527,"marketCap":10636929613},{"date":"2026-02-27","current":-9.574146,"twenty":-11.38719,"median":-10.509847,"eighty":-9.836956,"marketCap":10148045662},{"date":"2026-03-06","current":-8.841756,"twenty":-11.29428,"median":-10.416014,"eighty":-9.744297,"marketCap":9296202413},{"date":"2026-03-13","current":-10.316011,"twenty":-11.38719,"median":-10.450758,"eighty":-9.761464,"marketCap":10896186254},{"date":"2026-03-20","current":-10.186272,"twenty":-11.29428,"median":-10.385171,"eighty":-9.744297,"marketCap":10718410272},{"date":"2026-03-27","current":-5.945762,"twenty":-11.270982,"median":-10.329745,"eighty":-9.723416,"marketCap":12081359470},{"date":"2026-04-02","current":-6.621163,"twenty":-11.205287,"median":-10.312136,"eighty":-9.574146,"marketCap":13518381995},{"date":"2026-04-10","current":-7.067323,"twenty":-11.18954,"median":-10.310332,"eighty":-9.547859,"marketCap":14540593893},{"date":"2026-04-17","current":-8.194366,"twenty":-11.170082,"median":-10.271344,"eighty":-9.114302,"marketCap":16866496330},{"date":"2026-04-24","current":-11.736244,"twenty":-11.170082,"median":-10.248784,"eighty":-8.950161,"marketCap":18318333519},{"date":"2026-04-30","current":-10.233962,"twenty":-11.173069,"median":-10.230093,"eighty":-8.995356,"marketCap":15977616418},{"date":"2026-05-08","current":-9.881779,"twenty":-11.158327,"median":-10.186272,"eighty":-9.095725,"marketCap":15481325134},{"date":"2026-05-15","current":-8.422278,"twenty":-11.148553,"median":-10.161068,"eighty":-8.948635,"marketCap":13229496023},{"date":"2026-05-22","current":-7.916926,"twenty":-11.098455,"median":-10.138144,"eighty":-8.800358,"marketCap":12407282105},{"date":"2026-05-29","current":-8.035507,"twenty":-11.019944,"median":-10.082937,"eighty":-8.624127,"marketCap":12636909415},{"date":"2026-06-05","current":-6.909175,"twenty":-10.994143,"median":-10.039967,"eighty":-8.441141,"marketCap":10881371589},{"date":"2026-06-12","current":-6.584396,"twenty":-10.981505,"median":-9.989391,"eighty":-8.291507,"marketCap":10362858307},{"date":"2026-06-18","current":-6.718884,"twenty":-10.969649,"median":-9.941921,"eighty":-8.193596,"marketCap":10599892950},{"date":"2026-06-26","current":-5.732708,"twenty":-10.937065,"median":-9.927249,"eighty":-8.035507,"marketCap":8999909109},{"date":"2026-07-03","current":-7.180567,"twenty":-10.922684,"median":-9.900616,"eighty":-7.915515,"marketCap":11281367549},{"date":"2026-07-10","current":-9.054005,"twenty":-10.894174,"median":-9.893411,"eighty":-7.915515,"marketCap":14207263926},{"date":"2026-07-17","current":-8.396292,"twenty":-10.887172,"median":-9.884317,"eighty":-7.956496,"marketCap":13222088691},{"date":"2026-07-24","current":-8.187485,"twenty":-10.884642,"median":-9.862553,"eighty":-8.009423,"marketCap":12896166056},{"date":"2026-07-31","current":-6.510345,"twenty":-10.870773,"median":-9.833804,"eighty":-7.907869,"marketCap":10273970316},{"date":"2026-08-07","current":-7.003679,"twenty":-10.846908,"median":-9.792157,"eighty":-7.575355,"marketCap":11073962237},{"date":"2026-08-14","current":-7.214728,"twenty":-10.805358,"median":-9.754197,"eighty":-7.296139,"marketCap":11422106869},{"date":"2026-08-21","current":-7.917767,"twenty":-10.771121,"median":-9.6954,"eighty":-7.255608,"marketCap":12562836089},{"date":"2026-08-26","current":-7.549865,"twenty":-10.75778,"median":-9.667608,"eighty":-7.286411,"marketCap":11977656814}],"updateTime":1787828835159},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02595\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630325016","title":"Genfleet Therapeutics (Shanghai) Inc -  All Entities, Products or Disputed Matters Referenced in Revmed's Correspondence  Entirely Unrelated to Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2630325016","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630325016?lang=en_us&edition=fundamental","pubTime":"2026-04-28 12:29","pubTimestamp":1777350598,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41A159:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630021325","title":"GenFleet says GFH276 IP independent, not tied to RevMed RAS patent disputes","url":"https://stock-news.laohu8.com/highlight/detail?id=2630021325","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630021325?lang=en_us&edition=fundamental","pubTime":"2026-04-28 12:29","pubTimestamp":1777350595,"startTime":"0","endTime":"0","summary":"GenFleet issued a clarification saying its Pan RAS  inhibitor GFH276 is unrelated to patent or trade secret disputes referenced in correspondence from Revolution Medicines on RAS inhibitors.GenFleet stated GFH276 was developed using independent, proprietary intellectual property, with no exposure to infringement or trade secret risks tied to those disputes.Company highlighted a global patent portfolio for its Pan RAS program, citing publication of a core patent covering GFH276’s compound structure on March 6, 2025.GenFleet said patent protection for that core filing is projected to run through 2044.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics  Inc. published the original content used to generate this news brief","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLb3WJHz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","02595","RVMD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145605681","title":"GENFLEET-B Surges Over 7% in Morning Session as Two GFH375/VS-7375 Preclinical Studies Selected for Late-Breaking Research Abstracts","url":"https://stock-news.laohu8.com/highlight/detail?id=1145605681","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145605681?lang=en_us&edition=fundamental","pubTime":"2026-04-24 12:05","pubTimestamp":1777003535,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) saw its shares rise by 7.34% in morning trading, currently priced at HKD 48.58, with a turnover of HKD 52.61004 million. On April 23, according to an announcement from GENFLEET-B,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK4085","VS","BK1574","BK1161","02595","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181471426","title":"GENFLEET-B Shares Surge Over 4% in Morning Session on Release of Preclinical Data for Pan-RAS Inhibitor GFH276","url":"https://stock-news.laohu8.com/highlight/detail?id=1181471426","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181471426?lang=en_us&edition=fundamental","pubTime":"2026-04-22 12:02","pubTimestamp":1776830523,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) saw its shares rise nearly 6% during the trading session. At the time of writing, the stock was up 4.41%, trading at HK$45.94, with a turnover of HK$21.2173 million. GENFLEET...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","159938","BK1574","BK1161","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105867730","title":"Stock Track | Genfleet Therapeutics Soars 5.55% Intraday on Strong Revenue Growth, Buyback Plan, and Breakthrough Therapy Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1105867730","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105867730?lang=en_us&edition=fundamental","pubTime":"2026-04-22 11:36","pubTimestamp":1776829001,"startTime":"0","endTime":"0","summary":"Genfleet Therapeutics-B (02595.HK) saw its stock price soar 5.55% during intraday trading on Wednesday, driven by a cluster of positive company-specific developments.The rally follows the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135051908","title":"GenFleet Therapeutics to Seek Shareholder Nod for Share Mandates, Governance Revamp at 11 May 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1135051908","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135051908?lang=en_us&edition=fundamental","pubTime":"2026-04-17 23:03","pubTimestamp":1776438192,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. has called its 2025 annual general meeting for 11 May 2026 in Shanghai to vote on a broad slate of corporate and capital-management proposals. Key agenda items...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157627828","title":"GenFleet Therapeutics Schedules 11 May 2026 AGM to Approve 2025 Results, Auditor Re-Appointment and Share Buy-Back Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=1157627828","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157627828?lang=en_us&edition=fundamental","pubTime":"2026-04-17 23:03","pubTimestamp":1776438180,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. will convene its 2026 Annual General Meeting on 11 May 2026 at 10:00 a.m. in the company’s meeting room at Building 73, Lane 1000, Zhangheng Road, Pudong New...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113362583","title":"GenFleet Therapeutics Sets 11 May 2026 AGM; Targets 10% Share Buy-back and 20% Issuance Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1113362583","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113362583?lang=en_us&edition=fundamental","pubTime":"2026-04-17 23:02","pubTimestamp":1776438176,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. will hold its 2025 Annual General Meeting on 11 May 2026 at 10:00 a.m. in Shanghai. Shareholders will vote on 11 resolutions, covering routine reporting items,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628207233","title":"Genfleet Therapeutics announces annual general meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2628207233","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628207233?lang=en_us&edition=fundamental","pubTime":"2026-04-17 22:47","pubTimestamp":1776437226,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics scheduled 2025 annual general meeting in Shanghai on May 11, 2026.Shareholders set to vote on 2025 board report, audited consolidated financial statements, annual report.Meeting agenda includes 2025-2026 directors’ remuneration package, reappointment of Ernst & Young as 2026 auditor.Special resolutions seek mandates to repurchase up to 10% of issued shares, issue up to 20% of issued shares, including sale or transfer of treasury shares.Proposals also cover amendments to corporate governance systems, including procedures for shareholders’ meetings, board of directors, independent non-executive directors, related party transaction management.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics  Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDLb6tsfV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628520748","title":"Genfleet Therapeutics publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2628520748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628520748?lang=en_us&edition=fundamental","pubTime":"2026-04-17 22:43","pubTimestamp":1776437000,"startTime":"0","endTime":"0","summary":"Genfleet Therapeutics released its 2025 annual report, highlighting progress across its RAS-focused oncology pipeline following its Hong Kong listing on Sept. 19, 2025.Flagship KRAS G12D candidate GFH375 entered world’s first phase III registrational oral KRAS G12D monotherapy trial in Nov. 2025 for metastatic pancreatic cancer.Commercial product fulzerasib, China’s first marketed KRAS G12C inhibitor, secured inclusion in National Reimbursement Drug List in Dec. 2025 with reimbursement effective in 2026.Pipeline expansion continued with Pan RAS inhibitor GFH276 entering clinic in Sept. 2025, while cachexia bispecific antibody GFS202A dosed first patient in March 2025.Genfleet reported steady revenue growth driven by licensing partnerships, supported by cash and bank balances above RMB 2 billion at end-2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gener","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL1HrT1D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111141151","title":"GENFLEET-B Receives \"Buy\" Rating and HK$55.63 Target Price in Initiation Coverage by Guojin Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1111141151","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111141151?lang=en_us&edition=fundamental","pubTime":"2026-04-15 15:14","pubTimestamp":1776237274,"startTime":"0","endTime":"0","summary":"Guojin Securities has initiated coverage on GENFLEET-B (02595) with a \"Buy\" rating. The firm projects the company's sales revenue for 2026, 2027, and 2028 to be RMB 146 million, RMB 160 million, and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","159938","02595","BK1161","BK1515","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194083813","title":"Stock Track | Genfleet Therapeutics-B Soars 5.48% Intraday on Breakthrough Therapy Designation for KRAS G12D Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=1194083813","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194083813?lang=en_us&edition=fundamental","pubTime":"2026-04-15 09:39","pubTimestamp":1776217187,"startTime":"0","endTime":"0","summary":"Genfleet Therapeutics-B (02595.HK) saw its stock price soar 5.48% during intraday trading on Wednesday, extending its recent positive momentum.The surge follows the company's announcement that its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164883301","title":"GENFLEET-B Shares Surge Over 5% in Morning Session on Second Breakthrough Therapy Designation for GFH375","url":"https://stock-news.laohu8.com/highlight/detail?id=1164883301","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164883301?lang=en_us&edition=fundamental","pubTime":"2026-04-09 09:38","pubTimestamp":1775698699,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) rose more than 5% during morning trading. At the time of writing, the stock was up 4.55% to HK$37.2, with a turnover of HK$5.53 million. The increase follows an announcement from...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4588","BK1161","159938","BK1515","BK4585","09939","VXUS","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626979113","title":"BRIEF-Genfleet Therapeutics (Shanghai) Says GFH375 Granted Breakthrough Therapy Designation By China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2626979113","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626979113?lang=en_us&edition=fundamental","pubTime":"2026-04-09 09:19","pubTimestamp":1775697597,"startTime":"0","endTime":"0","summary":"BRIEF-Genfleet Therapeutics (Shanghai) Says GFH375 Granted Breakthrough Therapy Designation By China's NMPAApril 9 (Reuters) - GenFleet Therapeutics (Shanghai) Inc 2595.HK:GFH375 GRANTED BREAKTHROUGH ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40R1FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166167640","title":"GENFLEET-B's GFH375 Granted Second Breakthrough Therapy Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1166167640","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166167640?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:14","pubTimestamp":1775693673,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that its oral KRAS G12D (ON/OFF) inhibitor, GFH375, has been included in the Breakthrough Therapy Designation (BTD) list by the Center for Drug Evaluation of the National...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","02595","BK1515","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626975327","title":"GenFleet says China grants breakthrough designation for GFH375 in metastatic pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2626975327","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626975327?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:00","pubTimestamp":1775692848,"startTime":"0","endTime":"0","summary":"GenFleet KRAS G12D inhibitor GFH375 won Breakthrough Therapy Designation from China drug regulator for monotherapy in KRAS G12D-mutant metastatic pancreatic cancer patients who received at least one prior systemic therapy.Designation marks first China BTD listing for KRAS G12D inhibitor monotherapy in pancreatic cancer.GenFleet said GFH375 entered phase III registrational study in 2025 across about 40 clinical sites in China.Partner Verastem began ex-China development in 2025 under name VS-7375.Verastem’s VS-7375 also received US FDA Fast Track status for KRAS G12D-mutant pancreatic ductal adenocarcinoma.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics  Inc. published the original content used to generate this news","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL5m3rYP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK4139","VSTM","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626755829","title":"Genfleet Therapeutics (Shanghai) Inc - Gfh375 Granted Breakthrough Therapy Designation by China's National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2626755829","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626755829?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:00","pubTimestamp":1775692847,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40R1FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625629489","title":"3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 46.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625629489","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625629489?lang=en_us&edition=fundamental","pubTime":"2026-04-06 06:04","pubTimestamp":1775426660,"startTime":"0","endTime":"0","summary":"Amidst ongoing geopolitical tensions and energy market volatility, Asian markets have displayed mixed performance, with investors navigating both regional challenges and opportunities. In this environment, identifying undervalued stocks can be a strategic approach for investors seeking potential value plays, especially when these stocks are trading at significant discounts relative to their intrinsic worth.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2595/genfleet-therapeutics-shanghai-shares/news/3-asian-stocks-estimated-to-be-trading-at-discounts-of-up-to-32","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2595/genfleet-therapeutics-shanghai-shares/news/3-asian-stocks-estimated-to-be-trading-at-discounts-of-up-to-32","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VGL.NZ","BK1161","02595","BK8007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176661857","title":"Wellington Management Increases Stake in GENFLEET-B by Approximately 318,247 Shares at Average Price of HK$30.88","url":"https://stock-news.laohu8.com/highlight/detail?id=1176661857","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176661857?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:32","pubTimestamp":1774870347,"startTime":"0","endTime":"0","summary":"On March 26, Wellington Management Group LLP purchased an additional 318,247 shares of GENFLEET-B (02595) at an average price of HK$30.8754 per share, according to the latest data from the Hong Kong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","EWH","02595","BK1161","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622891431","title":"GenFleet Therapeutics SEHK 2595 Deepens Losses As Revenue Growth Tests Bullish Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2622891431","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622891431?lang=en_us&edition=fundamental","pubTime":"2026-03-27 03:05","pubTimestamp":1774551916,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) (SEHK:2595) has just released its FY 2025 figures, with first half revenue at C¥88.7 million and basic EPS at a loss of C¥27.02 per share, setting the tone for a period where margins remain firmly in loss-making territory. The company has seen first half revenue move from C¥0 in 2024 to C¥88.7 million in 2025, while basic EPS shifted from a loss of C¥18.02 to a deeper loss of C¥27.02. This puts the spotlight on how quickly revenue can scale against persistent...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2595/genfleet-therapeutics-shanghai-shares/news/genfleet-therapeutics-sehk-2595-deepens-losses-as-revenue-gr","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2595/genfleet-therapeutics-shanghai-shares/news/genfleet-therapeutics-sehk-2595-deepens-losses-as-revenue-gr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BLSX","BK4112","BK1161","02595","BLSG","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":106,"code":"91000000","status":"200"}]}}